Information Provided By: 
Fly News Breaks for February 28, 2020
AHCO
Feb 28, 2020 | 08:28 EDT
Deutsche Bank analyst Pito Chickering raised the firm's price target on AdaptHealth to $19 from $12 and keeps a Buy rating on the shares. The company reported "solid" results in its first full quarter as a public company with revenues up 38% year-over-year and EBITDA rising 31%, Chickering tells investors in a research note.
News For AHCO From the Last 2 Days
There are no results for your query AHCO
